Ph.d. forsvar: Sacha Louise Sølbeck

​Dabigatran monitoring by TEG® in vitro and in Atrial Fibrillation patients compared to plasma-based tests and in vitro reversal of dabigatran by PCC and rFVIIa

Tidspunkt Ikon
Dato: 12-10-2017
Tid: 14:00 - 17:00
$Resources:Resource,alt_meeting_place;

​Auditorium 93

Tilmelding

​Ingen tilmelding. Alle er velkomne.

Redaktør